Generated by AI
CDT Equity Inc. is a data-driven biopharmaceutical company focused on identifying, enhancing, and advancing therapeutic assets through scientific innovation and strategic partnerships. CDT Equity Inc. develops clinical-stage programs across autoimmune diseases, oncology, dermatology, idiopathic male infertility, rare diseases, and animal health. Its current portfolio includes compounds such as AZD1656, AZD5658, and AZD5904, supported by an approach that combines artificial intelligence, solid-form chemistry, and asset repositioning to improve development efficiency. The company emphasizes value creation through intellectual property, out-licensing, and partnerships rather than large-scale internal drug development. CDT Equity Inc. serves as a specialized participant in the healthcare sector, aiming to bring differentiated treatment candidates into clinical and commercial pathways.
Website4995 Murphy Canyon Road
San Diego, CA, 92123
United States
The latest articles about CDT.
Detailed price information for Cdt Equity Inc (CDT-Q) from The Globe and Mail including charting and trades.
Summary of Nov 18's posts. Generated by AI.
Summary of Nov 18's posts. Generated by AI.
Summary of Apr 11's posts. Generated by AI.
Summary of Nov 18's posts. Generated by AI.
Investors talking about CDT also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.